Clinical Trial Update: The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial evaluating oral semaglutide on bone turnover in type 2 diabetes mellitus with osteopenia. The study status is act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Odense University Hospital | Conditions: Type 2 Diabetes, Osteopenia | Phase 2 | Status: ACTIVE_NOT_RECRUITING